Homepage

Immuno US 2024

October 2024 | San Diego, USA

Discuss the latest strategies to harness the immune system for the development of innovative therapeutics

Featuring 200+ presentations, the event brings together over 500 attendees from leading pharma, biotech and academic organisations designing innovative strategies and technologies for more effective cancer immunotherapy development.

Programmes

Key Speakers

The 2024 event again brings together a panel of prominent leaders and scientists, sharing new case studies, innovative data and industry outlook.

Below were the key speakers for Immuno US 2023

Sailaja Battula

Senior Director, Translational Research

Ankyra Therapeutics

Aditya Murthy

Director, Oncology

Gilead Sciences

Jean-Francois Martini

Executive Director, Translational Oncology Lead, Global Product Development

Pfizer

Event Features

Networking & knowledge-sharing is at the heart of what we do. Alongside the innovative programme, attendees can engage in a variety of event features and make the most of participation in a range of on-site experiences.

Poster Display

Enhance your attendance with an A0 Poster, based in our main networking hall

Submit Abstract

Networking Drinks

Relax after a busy first day at the event with access to the vibrant drinks reception

Enquire

Event App

Our Event App features a personalisable agenda, peer-to-peer networking, OnDemand Presentations, solution provider content, and much more!

Sponsorship

A range of customisable opportunities for lead generation, brand building and global business deals. Whether you’re looking to build business, product launch or increase visibility, we provide a variety of highly effective options to suit budget and requirement.

Download Brochure

"I liked the long networking events between the talks. Also, I liked how the networking breaks/meals were in the same area as the exhibit booths. I think that we definitely got more traffic to our booth because of this arrangement. Also, I liked the wide range of presentation topics."

“The event was very well organized and had a very targeted audience.”

"It's a focused conference with two relevant themes, biomarker and IO. Right amount of presentation so easier to digest. Small but much easier to talk to people for scientific discussion. Speakers from both academia and industry represented a good breath of topics. I learned good deal on cell therapies.”

"I liked the smaller, more intimate setting and the inclusion of vendor talks to describe their companies capabilities."

"The vendors were really relevant to my work and the presentations were outstanding."